Content area
Abstract
DementiaGuide.com is the world's only complete disease management platform for Alzheimer's disease. These software products, currently partially developed, represent a revolutionary change in the method of educating patients, caregivers, and physicians. Their three interactive software products will be downloaded over the Internet, and available on CD-ROM. They also provide educational material, textbooks and videos on the subject of Dementia and Alzheimer's disease. Their target market is the over 6 million people in North America affected by Alzheimer's disease, their families and physicians. They are forming partnerships with International Pharmaceutical companies, and health management organizations in the US. These sales and distribution channels will complement their on-line sales. They offer a disease management program that is dynamic, alive, and improves the quality of life of millions. They are seeking financing of US$ 2.2 million in equity financing. This constitutes 12 % ownership in DementiaGuide. The return on investment is 813% over three years, with an easy exit strategy of sale through acquisition or IPO.